Meeting Report
Cancer-Associated Thrombosis: Risk Assessment, Prevention, and Treatment
Presented by Keri Halsema, NP, and Brandon McMahon, MD
From University of Colorado, Aurora, Colorado
Presenters’ disclosures of conflicts of interest are found at the end of this article.
J Adv Pract Oncol 2023;14(3):213–217 |
https://doi.org/10.6004/jadpro.2023.14.3.6 |
© 2023 Harborside™
ABSTRACT
The risk of developing venous thromboembolism (VTE) is four to seven times higher in patients with cancer than in those without. At JADPRO Live 2022, presenters discussed risk factors and assessing patients for VTE, as well as how to protect patients against VTE in both the inpatient and outpatient clinic settings. They reviewed selecting an appropriate anticoagulation treatment, including the choice of agent and duration of treatment for the patient with cancer, and finally the steps needed to assess and treat patients experiencing therapeutic anticoagulation failure.
For access to the full length article, please
sign in.
